Chronic administration of olmesartan attenuates the exaggerated pressor response to glutamate in the rostral ventrolateral medulla of SHR

Brain Research

Volumn 1058, Issue 1-2, 2005, Pages 161-166

  Lin, Yingzi ^a   Matsumura, Kiyoshi ^a   Kagiyama, Shuntaro ^a   Fukuhara, Masayo ^a   Fujii, Koji ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Glutamate; Hypertension; Rat; Rostral ventrolateral medulla

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; GLUTAMIC ACID; IONOTROPIC RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID; OLMESARTAN;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RESPONSE; DRUG MECHANISM; DRUG RESPONSE; MALE; MICROINJECTION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RAT STRAIN; SPINAL CORD COMPRESSION; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AUTONOMIC PATHWAYS; BLOOD PRESSURE; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; HYPERTENSION; IMIDAZOLES; MALE; MEDULLA OBLONGATA; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, N-METHYL-D-ASPARTATE; RETICULAR FORMATION; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION; TETRAZOLES; TREATMENT OUTCOME; VASOCONSTRICTION;

EID: 26244453700     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.07.070     Document Type: Article

References (23)

1. 1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and l-glutamate in rostral ventrolateral medulla Brain Res. 665 1994 245 252
2. C. Bergamaschi, R.R. Campos, N. Schor, and O.U. Lopes Role of the rostral ventrolateral medulla in maintenance of blood pressure in rats with Goldblatt hypertension Hypertension 26 1995 1117 1120
3. B. Dahlöf, R.B. Devereux, S.E. Kjeldsen, S. Julius, G. Beevers, U. de Faire, F. Fyhrquist, H. Ibsen, K. Kristiansson, O. Lederballe-Pedersen, L.H. Lindholm, M.S. Nieminen, P. Omvik, S. Oparil, and H. Wedel Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995 1003
4. M. de Gasparo, K.J. Catt, T. Inagami, J.W. Wright, and T. Unger International union of pharmacology: XXIII. The angiotensin II receptors Pharmacol. Rev. 52 2000 415 472
5. L. Hu, D.-A. Zhu, Z. Yu, J.Q. Wang, Z.-J. Sun, and T. Yao Expression of angiotensin II type 1 (AT1) receptor in the rostral ventrolateral medulla in rats J. Appl. Physiol. 92 2002 2153 2161
6. H. Lithell, L. Hansson, I. Skoog, D. Elmfeldt, A. Hofman, B. Olofsson, P. Trenkwalder, and A. Zanchetti The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial J. Hypertens. 21 2003 875 886
7. T. Matsuura, H. Kumagai, A. Kawai, H. Onimaru, M. Imai, N. Oshima, K. Sakata, and T. Saruta Rostral ventrolateral medulla neurons of neonatal Wistar-Kyoto and spontaneously hypertensive rats Hypertension 40 2002 560 565
8. M. Mayer, and G.L. Westbrook The physiology and excitatory amino acids in the vertebrate central nervous system Prog. Neurobiol. 28 1987 197 276
9. H. Muratani, D.B. Averill, and C.M. Ferrario Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats Am. J. Physiol. 260 1991 R977 R984
10. 1 receptors Brain Res. 871 2000 29 38
11. G. Paxinos C. Watson The Rat Brain in Stereotaxic Coordinates 2nd edn. 1986 Academic Press New York, NY
12. M.I. Phillips, and C. Sumners Angiotensin II in central nervous system physiology Regul. Pept. 78 1998 1 11
13. M.I. Phillips, L. Shen, E.M. Richards, and M.K. Raizada Immunohistochemical mapping of angiotensin AT1 receptors in the brain Regul. Pept. 44 1993 95 107
14. P.M. Pilowsky, and A.K. Goodchild Baroreceptor reflex pathways and neurotransmitters: 10 years on J. Hypertens. 20 2002 1675 1688
15. J.-P. Pin, and R. Duvoisin Review: neurotransmitter receptors I. The metabotropic glutamate receptors: structure and functions Neuropharmacology 34 1995 1 26
16. P.J. Privitera, H. Thibodeaux, and P. Yates Rostral ventrolateral medulla as a site for the central hypertensive action of kinins Hypertension 23 1994 52 58
17. D. Schoepp, J. Bockaert, and F. Sladeczek Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors Trends Pharmacol. Sci. 11 1990 508 515
18. J. Schrader, S. Lüders, A. Kulschewski, J. Berger, W. Zidek, J. Treib, K. Einhäupl, H.C. Diener, and P. Dominiak The ACCESS study. Evaluation of acute candesartan cilexetil therapy in stroke survivors Stroke 34 2003 1699 1703
19. 1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats Brain Res. 1028 2004 9 18
20. A.F. Sved, S. Ito, and J.C. Sved Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla Curr. Hypertens. Rep. 5 2003 262 268
21. T. Tsuchihashi, S. Kagiyama, U. Onaka, I. Abe, and M. Fujishima Pressor and sympathetic responses to excitatory amino acids are not augmented in the ventrolateral medulla of Dahl salt-sensitive rats Brain Res. 750 1997 195 200
22. T. Tsuchihashi, S. Kagiyama, Y. Ohya, I. Abe, and M. Fujishima Antihypertensive treatment and the responsiveness to glutamate in ventrolateral medulla Hypertension 31 1998 73 76
23. T. Tsuchihashi, S. Kagiyama, K. Matsumura, I. Abe, and M. Fujishima Effects of chronic oral treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in ventrolateral medulla of SHR J. Hypertens. 17 1999 917 922